Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Monday Market Glance – Jobs, Commodities, and 5 Small-Cap Stocks Deutsche Bank Says Deserve a Buy

Share On Facebook
share on Linkedin

Major indices are drifting between marginal gains and losses in Monday’s morning session, slowing the pace from Friday’s rally on good but not great jobs figures. The Labor Department showed the economy added 175,000 jobs in May, beating analyst expectations for 158,000 – however, the unemployment rate nudged higher to 7.6%. Without any major corporate news or economic reports on tap, investors have more time to digest the jobs report and ongoing stimulus measures.

Gold is down $4.50, or 0.33%, at $1,378.50, below the psychological comfort mark of $1,400 – silver is up $0.042, or 0.19%, in electronic trade at $21.78. Oil is down $0.53, or 0.55% at $95.50.

In the small cap sector, stocks swayed between slight gains and losses, mimicking large-cap counterparts. Deutsche Bank A.G. added weight to five stocks this morning when the firm issued a list of small caps making its Buy list, as initially reported by 247WallSt.

Ciena Corp. (CIEN) this morning climbed more than 1% to $19.99 as Deutsche highlighted the telecom equipment company’s recent Q2 earnings, which topped analyst estimates in EPS and sales, in addition to favorable guidance. Shares of CIEN surged 17.4% following its earnings release Thursday. Deutsche has a price target of $22 on the stock.

Gambling supplier SHFL entertainment (SHFL) is up nearly 2% at $18.05 mid-morning. Deutsche noted the 16% increase in the company’s electronic gaming machine sales as well as revenue from table games, proprietary games, shufflers and other products, which generated smaller contribution to sales. Deutsche raised its price target on the stock to $22 from $20.

Isle of Capri Casinos (ISLE) also made the Buy list. Deutsche has a price target of $8 on the casino gaming owner and operator. Shares are down 0.4% at $7.76 in mid-morning trade.

Deutsche has a price target of $40 on the stock of Alnylam Pharmaceuticals (ANLY), which also made the Buy list on the account of growth potential stemming from its IP rights to a Nobel Prize winning technology. The firm’s price target widely tops consensus estimate of $31. Shares of ANLY are firm at $4.13.

Next up is Achillion Pharmaceuticals (ACHN), up 0.8% at $8.34, pulling off an early morning dive. Deutsche points out that the company makes up 0.2% of the iShares Russell Microcap (IWC) and slapped shares with a price target of $17 (current trade is $8.34 per share).

Cyber security company Proofpoint (PFPT) is up 1.6% at $22.15. Deutsche pointed to the results of a survey the company conducted in May, which revealed the continuous “serious threat” of e-mail attacks at specific organizations. Deutsche raised its price target on the stock to $26 from $24.

The Russell 2000 (^RUT) is up 0.2% at 989.63 while iShares Russell Microcap (IWC) is up 0.4% at 62.10.

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

To learn more, visit

Please see disclaimer on the QualityStocks website:

Click Here to register for free on Investors Hub

This area of the site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of Investors Hub. Investors Hub does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at Investors Hub is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.

Comments are closed